Friday, January 27, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Genzyme inflated its share price by concealing its problems meeting FDA standards, shareholders claim in Boston Federal Court.

Allied Capital Corp. is selling itself too cheaply to Ares Capital, in an all-stock deal valued at $648 million or $3.47 a share, shareholders claim in Montgomery County Court, Md.

Zilog is selling itself too cheaply to Ixys, shareholders say in Santa Clara County Court, Calif.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.